Proteinuria with and without renal glomerular podocyte effacement

Journal of the American Society of Nephrology

Volumn 17, Issue 9, 2006, Pages 2383-2389

  Kalluri, Raghu ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 4; COLLAGEN TYPE 4ALPHA3; NEPHRIN; SLIT PROTEIN; SOLUBLE VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CELL DAMAGE; DISEASE MODEL; DISEASE SEVERITY; ENDOTHELIUM; GENE DELIVERY SYSTEM; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; KIDNEY BIOPSY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA;

EID: 33748062325     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006060628     Document Type: Article

References (49)

1. Hamano Y, Grunkemeyer JA, Sudhakar A, Zeisberg M, Cosgrove D, Morello R, Lee B, Sugimoto H, Kalluri R: Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 30: 30, 2002
2. Salant DJ: The structural biology of glomerular epithelial cells in proteinuric diseases. Curr Opin Nephrol Hypertens 3: 569-574, 1994
3. Kerjaschki D: Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases. Kidney Int 45: 300-313, 1994
4. Karnovsky MJ, Ainsworth SK: The structural basis of glomerular filtration. Adv Nephrol Necker Hosp 2: 35-60, 1972
5. Kaysen GA, Myers BD, Couser WG, Rabkin R, Felts JM: Mechanisms and consequences of proteinuria. Lab Invest 54: 479-498, 1986
6. Kerjaschki D: Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 108: 1583-1587, 2001
7. Kojima K, Davidovits A, Poczewski H, Langer B, Uchida S, Nagy-Bojarski K, Hovorka A, Sedivy R, Kerjaschki D: Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction. J Am Soc Nephrol 15: 2079-2089, 2004
8. Couser WG: Mechanisms of glomerular injury. An overview. Semin Nephrol 11: 254-258, 1991
9. Farquhar MG: Editorial: The primary glomerular filtration barrier-basement membrane or epithelial slits? Kidney Int 8: 197-211, 1975
10. Brenner BM: Retarding the progression of renal disease. Kidney Int 64: 370-378, 2003
11. Tripathi S, Tripathi K: Role of kidney in hypertension. J Indian Med Assoc 101: 260-262, 2003
12. Schieppati A, Remuzzi G: The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: Frustration and promises. Kidney Int 64: 1947-1955, 2003
13. Brenner BM: Regarding: Management of glomerular proteinuria: A commentary. J Am Soc Nephrol 15: 1354-1355; discussion 1356-1357, 2004
14. Kalluri R, Cosgrove D: Assembly of type IV collagen. Insights from alpha3(IV) collagen-deficient mice. J Biol Chem 275: 12719-12724, 2000
15. Kalluri R: Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003
16. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348: 2543-2556, 2003
17. Kanwar YS, Farquhar MG: Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81: 137-153, 1979
18. Mundel P, Schwarz K, Reiser J: Podocyte biology: A footstep further. Adv Nephrol Necker Hosp 31: 235-241, 2001
19. Reiser J, Kriz W, Kretzler M, Mundel P: The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 11: 1-8, 2000
20. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002
21. Moller CC, Pollak MR, Reiser J: The genetic basis of human glomerular disease. Adv Chronic Kidney Dis 13: 166-173, 2006
22. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983
23. Dvorak HF: Discovery of vascular permeability factor (VPF). Exp Cell Res 312: 522-526, 2006
24. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989
25. Gordon MS, Margolin K, Talpaz M, Sledge GW Jr, Holmgren E, Benjamin R, Stalter S, Shak S, Adelman D: Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19: 843-850, 2001
26. Margolin K, Gordon MS, Holmgren E, Gaudreault J, Novotny W, Fyfe G, Adelman D, Stalter S, Breed J: Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: Pharmacologic and long-term safety data. J Clin Oncol 19: 851-856, 2001
27. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS: A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59: 1540-1548, 1998
28. Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, Halmesmaki E: Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol 95: 353-357, 2000
29. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160: 1405-1423, 2002
30. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R: Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608, 2003
31. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99: 2470-2478, 1997
32. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10: 2981-2992, 1996
33. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998
34. Tryggvason K, Wartiovaara J: Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10: 543-549, 2001
35. Rantanen M, Palmen T, Patari A, Ahola H, Lehtonen S, Astrom E, Floss T, Vauti F, Wurst W, Ruiz P, Kerjaschki D, Holthofer H: Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephrol 13: 1586-1594, 2002
36. Topham PS, Kawachi H, Haydar SA, Chugh S, Addona TA, Charron KB, Holzman LB, Shia M, Shimizu F, Salant DJ: Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 104: 1559-1566, 1999
37. Orikasa M, Matsui K, Oite T, Shimizu F: Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 141: 807-814, 1988
38. Fujigaki Y, Morioka T, Matsui K, Kawachi H, Orikasa M, Oite T, Shimizu F, Batsford SR, Vogt A: Structural continuity of filtration slit (slit diaphragm) to plasma membrane of podocyte. Kidney Int 50: 54-62, 1996
39. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003
40. Kreisberg JI, Wayne DB, Karnovsky MJ: Rapid and focal loss of negative charge associated with mononuclear cell infiltration early in nephrotoxic serum nephritis. Kidney Int 16: 290-300, 1979
41. Macconi D, Ghilardi M, Bonassi ME, Mohamed EI, Abbate M, Colombi F, Remuzzi G, Remuzzi A: Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 11: 477-489, 2000
42. Farquhar MG, Vernier RL, Good RA: An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus. J Exp Med 106: 649-660, 1957
43. Farquhar MG, Vernier RL, Good RA: The application of electron microscopy in pathology: Study of renal biopsy tissues. Schweiz Med Wochenschr 87: 501-510, 1957
44. van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S: Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66: 1901-1906, 2004
45. Branten AJ, van den Born J, Jansen JL, Assmann KJ, Wetzels JF: Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney Int 59: 693-701, 2001
46. Good KS, O'Brien K, Schulman G, Kerjaschki D, Fogo AB: Unexplained nephrotic-range proteinuria in a 38-year-old man: A case of "no change disease." Am J Kidney Dis 43: 933-938, 2004
47. Seefeldt T, Bohman SO, Jorgen H, Gundersen HJ, Maunsbach AB, Petersen VP, Olsen S: Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis. Lab Invest 44: 541-546, 1981
48. Pirani CL, Pollak VE, Lannigan R, Folli G: The renal glomerular lesions of pre-eclampsia: Electron microscopic studies. Am J Obstet Gynecol 87: 1047-1070, 1963
49. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP: Preeclampsia: A renal perspective. Kidney Int 67: 2101-2113, 2005